The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALPHATEC HOLDINGS INC | COM | 02081G102 | 323 | 1,344,179 | SH | SOLE | 1,344,179 | 0 | 0 | ||
| QUINSTREET INC | COM | 74874Q100 | 924 | 270,114 | SH | SOLE | 270,114 | 0 | 0 | ||
| FIDUS INVT CORP | COM | 316500107 | 4,034 | 260,105 | SH | SOLE | 260,105 | 0 | 0 | ||
| TRANSENTERIX INC | COM NEW | 89366M201 | 14,792 | 3,480,512 | SH | SOLE | 3,480,512 | 0 | 0 | ||
| CAESARS ENTMT CORP | COM | 127686103 | 11,322 | 1,665,032 | SH | SOLE | 1,665,032 | 0 | 0 | ||
| CAESARS ACQUISITION CO | CL A | 12768T103 | 10,190 | 1,665,032 | SH | SOLE | 1,665,032 | 0 | 0 | ||
| VEEVA SYS INC | CL A COM | 922475108 | 4,006 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| NOVOCURE LTD | ORD SHS | G6674U108 | 26,288 | 1,815,479 | SH | SOLE | 1,815,479 | 0 | 0 | ||